Navigation Links
Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
Date:8/6/2012

http://ir.verenium.com/.  A replay of the event will be available on the Company's website approximately two hours after the call and will be archived for 30 days.

About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

Forward-Looking Statements Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's technology, products and product candidates and product pipeline, lines of business, operations (including Verenium's ability to successfully negotiate and enter into future collaborations and partnerships), capabilities, commercialization activities, customer adoption rates, industry conditions, future financial performance, and near-term and longer-term growth and prospects.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, technologies, products and product candidates and product pipeline (including Verenium's ability to identify, develop and commercialize new products and product candidates, either independently or with collaborators or partners, and market demand for those products and product candidates), dependence on patents and proprietary rights,  protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium
'/>"/>

SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Verenium Corporation To Announce Second Quarter 2012 Financial Results
2. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
3. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
4. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
5. Verenium Corporation To Announce First Quarter 2012 Financial Results
6. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
7. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
8. Verenium to Present at Baird Clean Technology Conference
9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
10. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
11. Discovery Labs Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... PuraMed BioScience ® , Inc., (OTCBB: ... (OTC) medicinal and healthcare products, announced that Ludlow ... based on low market capitalization valuation. ... Product to Treat Migraine Headaches , Clinical ... , Currently Available Nationwide at Walgreen,s and ...
(Date:5/23/2013)... May 23, 2013  Saddleback Memorial Medical Center in ... the first hospital on the West Coast to perform ... surgical option provides women with a state-of-the-art, minimally invasive ... Marc Winter , M.D., a highly regarded ... medical director of minimally invasive surgery at Saddleback Memorial, ...
(Date:5/23/2013)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... personalized immune therapies for solid tumor cancers, announced today ... American Society Of Clinical Oncology (ASCO) meeting in ... in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... pre-eminent conference focused on clinical treatment of cancer, with ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
... FT. MYERS, Fla., July 22 NeoGenomics, Inc. (OTC ... second quarter 2010 financial results on Thursday, July 29, 2010 . , ... The Company has scheduled a web-cast and ... , at 11:00 AM EDT .  Interested investors should dial (877) 407-9210 ...
... July 21, 2010 -- Scientists from the Hebrew University ... possible to greatly expand the memory capacity of future ... silica nanoparticles combined with protein molecules obtained from the ... they have developed an alternative avenue to miniaturize memory ...
... , July 21 The Lucian Leape Institute ... afternoon discussion and special evening program at its Third ... 2010 .  David Blumenthal, M.D., M.P.P., will deliver a keynote ... technology as a patient safety lever and the focus placed ...
Cached Biology Technology:NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010 2NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010 3Protein from poplar trees can be used to greatly increase computer capacity 2David Blumenthal, HHS National Coordinator for Health Information Technology, to Speak at Lucian Leape Institute Third Annual Forum & Gala on Sept. 16 2David Blumenthal, HHS National Coordinator for Health Information Technology, to Speak at Lucian Leape Institute Third Annual Forum & Gala on Sept. 16 3David Blumenthal, HHS National Coordinator for Health Information Technology, to Speak at Lucian Leape Institute Third Annual Forum & Gala on Sept. 16 4
(Date:5/23/2013)... around nucleosomes in the cell nucleus makes it ... (LMU) in Munich now describes a mechanism that ... nucleosomes for transcription. , In higher organisms the ... wrapped around disk-shaped particles called nucleosomes, each consisting ... and accommodating two loops of DNA. Packed in ...
(Date:5/23/2013)... HOUSTON (May 23, 2013) A new report ... responsible for helping pupils engage in at least 60 ... school day. , No more than half of American ... hour of vigorous or moderate intensity physical activity daily, ... , "Because children are in school for nearly half ...
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
Breaking Biology News(10 mins):Biochemistry: Unspooling DNA from nucleosomal disks 2Schools should provide students with daily physical activity, IOM recommends 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2
... University of Illinois study shows that human milk oligosaccharides, or ... population in the infant gut. Not only that, the bacterial ... change. Even though HMO are a major component of ... their actions in the infant are not well understood. Furthermore, ...
... JOLLA, CA ---- Scientists at the Salk Institute for ... of plant proteins that play a role in the ... human nutrition, biorenewable chemicals and biofuels. Scoring a ... related proteins in thale cress plants ( Arabidopsis thaliana ...
... Imagine charging your phone as you walk, thanks ... your shoe. This futuristic scenario is now a little ... Energy,s Lawrence Berkeley National Laboratory (Berkeley Lab) have developed ... convert mechanical energy into electricity. The scientists tested ...
Cached Biology News:Study sheds new light on importance of human breast milk ingredient 2Discovery of plant proteins may boost agricultural yields and biofuel production 2Discovery of plant proteins may boost agricultural yields and biofuel production 3Berkeley Lab scientists generate electricity from viruses 2Berkeley Lab scientists generate electricity from viruses 3
...
Contains L-glutamine....
Contains L-glutamine...
... Immunogen: Synthetic peptide derived from ... mouse and rat LRP5. ... mouse LRP5 proteins. Reactivity: ... LRP5-pSEC-tag-transfected 293T cells MCF-7 T47D ...
Biology Products: